IDCRP News

New evidence-based guideline for Antiepileptic drug selection for people with HIV/AIDS has been published in 2 journals, American Academy of Neurology and also Epilepsia. IDCRP-000 HIV Natural History Study data was a key piece for developing this guideline.

The IDCRP has an impressive eight abstracts accepted to the 2012 Conference on Retroviruses and Opportunistic Infections!

Abstract titles include:

A Comparison of HAART Outcomes Between the US Military HIV Natural History Study (NHS) and HIV Atlanta Veterans Affairs Cohort Study (HAVACS)

Identification of an Abbreviated Test Battery for Detection of HIV-associated Neurocognitive Impairment in an Early-Treated HIV-infected Cohort

Characteristics of Immunologic Nonresponders in an ARV-Naive, Advanced HIV Cohort in Kenya

Delayed-Type Hypersensitivity and Hepatitis B Vaccine Responses, in vivo Markers of Cellular and Humoral Immune Function, and the Risk of AIDS or Death

Hepatitis B Virus Vaccine Response Is Inversely Related to the Duration of Untreated HIV Infection

An Early Diagnosed and Treated HIV Cohort Shows Low Rates of Neurocognitive Impairment

Decreased MRSA-Specific CD4+ T cell Responses May Explain Predisposition to MRSA Skin and Soft Tissue Infections among HIV-Infected Persons

Correlates of Depression Among US Military Members Infected With the Human Immunodeficiency Virus Not Using Intravenous Drugs (IVDU) (IDCRP Staff Collaboration)